(Q46412218)

22 December 2017

title

Concomitant DFMO and sulindac chemoprevention of colorectal adenomas: a major clinical advance (English)

1 reference

22 December 2017

2

Waun Ki Hong

1 reference

22 December 2017

author name string

Michael B Sporn

series ordinal

1

1 reference

22 December 2017

publication date

26 August 2008

1 reference

22 December 2017

Nature Clinical Practice Oncology

published in

1 reference

22 December 2017

volume

5

1 reference

22 December 2017

issue

11

1 reference

22 December 2017

page(s)

628-629

1 reference

22 December 2017

Clinical prevention of recurrence of colorectal adenomas by the combination of difluoromethylornithine and sulindac: an important milestone

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

Combination chemoprevention of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

Recent advances in chemoprevention of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

Celecoxib for the prevention of sporadic colorectal adenomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC1221

7 January 2021

Identifiers

DOI

10.1038/NCPONC1221

1 reference

22 December 2017

PubMed ID

18725921

1 reference

22 December 2017